Akèy › Glomerilonefrit mbranè › North Carolina
Etid klinik pou Glomerilonefrit mbranè nan North Carolina
3 etid pou Glomerilonefrit mbranè ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
Belimumab With Rituximab for Primary Membranous Nephropathy
- University of North Carolina School of Medicine: Division of Nephrology and Hypertension, Kidney Center, Chapel Hill
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT03949855Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Ap rekrite
Laj 1 a 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT04571658Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.